Prognostic Significance of CD138 (Syndecan-1) Expression in Autoimmune Hepatitis

被引:0
|
作者
Romano, Adriana F.
Sauma-Rodriguez, Johanna
Ramos-Martinez, Paris
Torre, Aldo
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1832
引用
收藏
页码:S1008 / S1008
页数:1
相关论文
共 50 条
  • [41] Heparanase upregulates synthesis and expression of syndecan-1 (CD138) - A novel growth regulatory loop for myeloma tumors.
    Yang, Y
    MacLeod, V
    Theus, AM
    Sanderson, RD
    Zhan, FH
    Shaughnessy, J
    [J]. BLOOD, 2005, 106 (11) : 185A - 186A
  • [42] Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus
    Minowa, Kentaro
    Amano, Hirofumi
    Nakano, Souichiro
    Ando, Seiichiro
    Watanabe, Takashi
    Nakiri, Yutaka
    Amano, Eri
    Tokano, Yoshiaki
    Morimoto, Shinji
    Takasaki, Yoshinari
    [J]. AUTOIMMUNITY, 2011, 44 (05) : 357 - 362
  • [43] Role of the Heparan Sulfate Proteoglycan Syndecan-1 (CD138) in Delayed-Type Hypersensitivity
    Masouleh, Behzad Kharabi
    Ten Dam, Gerdy B.
    Wild, Martin K.
    Seelige, Ruth
    van der Vlag, Johan
    Rops, Angelique L.
    Echtermeyer, Frank G.
    Vestweber, Dietmar
    van Kuppevelt, Toin H.
    Kiesel, Ludwig
    Goette, Martin
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 182 (08): : 4985 - 4993
  • [44] CD138 (Syndecan-1), a plasma cell marker - Immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms
    O'Connell, FP
    Pinkus, JL
    Pinkus, GS
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (02) : 254 - 263
  • [45] Differential Expression of Syndecan-1/CD138 in Triple Negative Breast Carcinoma and Hormone Receptor Positive Breast Carcinoma
    Patel, S.
    Cohen, C.
    McLendon, L. A.
    Husman, A.
    Schmechel, S.
    Busch, R.
    Stevens, K.
    Adams, A.
    Oprea, G. M.
    [J]. MODERN PATHOLOGY, 2012, 25 : 58A - 58A
  • [46] Differential Expression of Syndecan-1/CD138 in Triple Negative Breast Carcinoma and Hormone Receptor Positive Breast Carcinoma
    Patel, S.
    Cohen, C.
    McLendon, L. A.
    Husman, A.
    Schmechel, S.
    Busch, R.
    Stevens, K.
    Adams, A.
    Oprea, G. M.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 58A - 58A
  • [47] Expression of Syndecan-1 (CD138) in Bladder Cancer with Emphasis on Conventional Urothelial Carcinoma and Urothelial Carcinoma with Squamous Differentiation
    Patel, S.
    Osunkoya, A. O.
    Ormenisan, C.
    Oprea-Ilies, G. M.
    [J]. MODERN PATHOLOGY, 2012, 25 : 234A - 234A
  • [48] Expression of Syndecan-1 (CD138) in Bladder Cancer with Emphasis on Conventional Urothelial Carcinoma and Urothelial Carcinoma with Squamous Differentiation
    Patel, S.
    Osunkoya, A. O.
    Ormenisan, C.
    Oprea-Ilies, G. M.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 234A - 234A
  • [49] Prognostic significance of syndecan-1 expression in human endometrial cancer
    Kodama, HJ
    Kusumoto, T
    Shinyo, Y
    Seki, N
    Hiramatsu, Y
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (07) : 1109 - 1115
  • [50] Syndecan-1 expression in gallbladder cancer and its prognostic significance
    Roh, Y. H.
    Kim, Y. H.
    Choi, H. J.
    Lee, K. E.
    Roh, M. S.
    [J]. EUROPEAN SURGICAL RESEARCH, 2008, 41 (02) : 245 - 250